论文部分内容阅读
乙型肝炎(HB)疫苗预防接种已降低了全球流行区人群中乙型肝炎病毒(HBV)的携带率及急性死亡率,而且HB疫苗有极好的安全性。 然而,目前在接受核苷类似物抗病毒治疗和肝移植后接受HB免疫球蛋白治疗的患
Vaccination with hepatitis B vaccines has reduced the carriage of hepatitis B virus (HBV) and acute mortality in people in endemic areas worldwide, and the HB vaccine has excellent safety. However, patients currently receiving treatment with HB immunoglobulin after antiviral treatment with nucleoside analogs and liver transplantation